Efficacy and safety of dapagliflozin in children with kidney disease: real-world data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and safety of dapagliflozin in children with kidney disease: real-world data ; volume:39 ; number:12 ; day:6 ; month:8 ; year:2024 ; pages:3551-3558 ; date:12.2024
Pediatric nephrology ; 39, Heft 12 (6.8.2024), 3551-3558, 12.2024
- Creator
-
Choi, Naye
Kim, Ji Hyun
Park, Peong Gang
Lee, Hyeonju
Min, Jeesu
Park, Hye Won
Ahn, Yo Han
Kang, Hee Gyung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-024-06481-8
- URN
-
urn:nbn:de:101:1-2501152122594.146651182663
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choi, Naye
- Kim, Ji Hyun
- Park, Peong Gang
- Lee, Hyeonju
- Min, Jeesu
- Park, Hye Won
- Ahn, Yo Han
- Kang, Hee Gyung
- SpringerLink (Online service)
Other Objects (12)
Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study
The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
Dapagliflozin
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy
Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness
Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study
The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
Dapagliflozin
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy
Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness
Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study
The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
Dapagliflozin
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy
Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety